Loading…
avatar for Robyn Bent

Robyn Bent

FDA, United States
Director, Patient Focused Drug Development Program, OCD, CDER
Robyn Bent joined the US FDA in 2019 as the director of CDER’s Patient-Focused Drug Development (PFDD) Initiative, an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making. Prior to joining FDA, Robyn was a Chief Scientific Program Specialist at the National Institutes of Health. Captain Bent has extensive experience in clinical trial design, conduct, and oversight. Robyn earned a Bachelor of Science in Nursing from The Catholic University of America and a Master of Science degree from the George Washington University.